Results 91 to 100 of about 8,218 (178)

Tnpo3 controls splicing of the pre-mRNA encoding the canonical TCR α chain of iNKT cells. [PDF]

Nat Commun, 2023
Iwanami N, Richter AS, Sikora K, Boehm T.   +3 more
europepmc   +1 more source

Generation of iPSC-Derived iNKT Cells with Pro-Hematopoietic Activity. [PDF]

Stem Cell Rev Rep
Kumar A, Ferguson S, D'Souza SS, Bharadwaj NS, Raymond M, Gumperz JE, Slukvin II.   +6 more
europepmc   +1 more source

New insights into iNKT cells and their roles in liver diseases. [PDF]

Front Immunol, 2022
Gu X, Chu Q, Ma X, Wang J, Chen C, Guan J, Ren Y, Wu S, Zhu H.   +8 more
europepmc   +1 more source

iNKT cells in chronic HBV: a balancing act [PDF]

Hepatology International, 2016
Hofmann, Maike, Thimme, Robert
openaire   +3 more sources

Human CD4⁺ iNKT cells have highly oxidative metabolism and use glycogen reserves to sustain IFN-γ production in nutrient-limited environments. [PDF]

Front Immunol
Patankar NM, Smith KA, Jacobsen N, Bharadwaj NS, Gumperz JE.   +4 more
europepmc   +1 more source

Invariant NKT cells are more abundant in peanut-allergic adults and a subset of CD8⁺ iNKT cells are depleted after peanut oil exposure. [PDF]

Front Immunol, 2023
Hopkins GV, Cochrane S, Onion D, Fairclough LC.   +3 more
europepmc   +1 more source

Human iNKT Cells Modulate Macrophage Survival and Phenotype. [PDF]

Biomedicines, 2022
Loureiro JP, Cruz MS, Cardoso AP, Oliveira MJ, Macedo MF.   +4 more
europepmc   +1 more source

Expression of CD38 on resting peripheral iNKT cells defines an immature subpopulation with distinct functionality in humans. [PDF]

Immunol Cell Biol
Menne C, Tavakolinia N, Perriman L, Moskorz W, Cosmovici C, Walker A, Olejnik L, Raba K, Du MR, Rossello FJ, Konstantinov IE, Berzins SP, Pellicci DG, Timm J.   +13 more
europepmc   +1 more source

Pbrm1 intrinsically controls the development and effector differentiation of iNKT cells. [PDF]

J Cell Mol Med, 2022
Wang X, Lei L, Su Y, Liu J, Yuan N, Gao Y, Yang X, Sun C, Ning B, Zhang B.   +9 more
europepmc   +1 more source

CAR-iNKT cells targeting clonal TCRVβ chains as a precise strategy to treat T cell lymphoma. [PDF]

Front Immunol, 2023
Rowan AG, Ponnusamy K, Ren H, Taylor GP, Cook LBM, Karadimitris A.   +5 more
europepmc   +1 more source